Matches in Nanopublications for { ?s ?p "[Interestingly, flow cytometry analysis of 20 samples of patients with acute myeloid leukemia (AML) (FAB M0-M5) revealed the expression of NKG2D (40%) and other natural cytotoxicity receptors (40% for NKp30, 74% for NKp44, 39% for NKp46) by a pool >15% of leukemic cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- NP244366.RAf_3ZBita8o6pF4exQE_P2V-cMrDYe2BByYEsfLrsAC0130_assertion description "[Interestingly, flow cytometry analysis of 20 samples of patients with acute myeloid leukemia (AML) (FAB M0-M5) revealed the expression of NKG2D (40%) and other natural cytotoxicity receptors (40% for NKp30, 74% for NKp44, 39% for NKp46) by a pool >15% of leukemic cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP244366.RAf_3ZBita8o6pF4exQE_P2V-cMrDYe2BByYEsfLrsAC0130_provenance.
- NP198532.RAZa_r9-Pm96yzIhJGUJ9nhPBKTv1_7n32A39pPEa8QIY130_assertion description "[Interestingly, flow cytometry analysis of 20 samples of patients with acute myeloid leukemia (AML) (FAB M0-M5) revealed the expression of NKG2D (40%) and other natural cytotoxicity receptors (40% for NKp30, 74% for NKp44, 39% for NKp46) by a pool >15% of leukemic cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP198532.RAZa_r9-Pm96yzIhJGUJ9nhPBKTv1_7n32A39pPEa8QIY130_provenance.
- NP699878.RATpoEoSqOGRiHEkVeoMskIbliIdwrW0bX_Dz6QPi_Vw4130_assertion description "[Interestingly, flow cytometry analysis of 20 samples of patients with acute myeloid leukemia (AML) (FAB M0-M5) revealed the expression of NKG2D (40%) and other natural cytotoxicity receptors (40% for NKp30, 74% for NKp44, 39% for NKp46) by a pool >15% of leukemic cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP699878.RATpoEoSqOGRiHEkVeoMskIbliIdwrW0bX_Dz6QPi_Vw4130_provenance.
- NP918738.RAkocNpVBM_tAxVT1v8oMKR8saTe9lMsowWspAngOropc130_assertion description "[Interestingly, flow cytometry analysis of 20 samples of patients with acute myeloid leukemia (AML) (FAB M0-M5) revealed the expression of NKG2D (40%) and other natural cytotoxicity receptors (40% for NKp30, 74% for NKp44, 39% for NKp46) by a pool >15% of leukemic cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP918738.RAkocNpVBM_tAxVT1v8oMKR8saTe9lMsowWspAngOropc130_provenance.
- NP714794.RAXX_UsqlM4cwxNbRM-X5LkGb6UITnGDaMe24iCNjo0oY130_assertion description "[Interestingly, flow cytometry analysis of 20 samples of patients with acute myeloid leukemia (AML) (FAB M0-M5) revealed the expression of NKG2D (40%) and other natural cytotoxicity receptors (40% for NKp30, 74% for NKp44, 39% for NKp46) by a pool >15% of leukemic cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP714794.RAXX_UsqlM4cwxNbRM-X5LkGb6UITnGDaMe24iCNjo0oY130_provenance.
- NP455152.RA33l_vT5r2PLbfDaCl7sX7aWwG8LiTtqj007VjsfHZGg130_assertion description "[Interestingly, flow cytometry analysis of 20 samples of patients with acute myeloid leukemia (AML) (FAB M0-M5) revealed the expression of NKG2D (40%) and other natural cytotoxicity receptors (40% for NKp30, 74% for NKp44, 39% for NKp46) by a pool >15% of leukemic cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP455152.RA33l_vT5r2PLbfDaCl7sX7aWwG8LiTtqj007VjsfHZGg130_provenance.
- NP744956.RAyJGggWaQ_CIOlUWRmy4WPNd9RpdPB2f_UONDn_8dEg8130_assertion description "[Interestingly, flow cytometry analysis of 20 samples of patients with acute myeloid leukemia (AML) (FAB M0-M5) revealed the expression of NKG2D (40%) and other natural cytotoxicity receptors (40% for NKp30, 74% for NKp44, 39% for NKp46) by a pool >15% of leukemic cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP744956.RAyJGggWaQ_CIOlUWRmy4WPNd9RpdPB2f_UONDn_8dEg8130_provenance.
- NP826951.RA71ZNPo_V6jtFtMOCskjBYSycebJyH2TzL6LDmhsFeSI130_assertion description "[Interestingly, flow cytometry analysis of 20 samples of patients with acute myeloid leukemia (AML) (FAB M0-M5) revealed the expression of NKG2D (40%) and other natural cytotoxicity receptors (40% for NKp30, 74% for NKp44, 39% for NKp46) by a pool >15% of leukemic cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP826951.RA71ZNPo_V6jtFtMOCskjBYSycebJyH2TzL6LDmhsFeSI130_provenance.
- NP504912.RAJ432_ETvk8cFlW7POk2UeT1y-sj8FKHvgFntIr9akWA130_assertion description "[Interestingly, flow cytometry analysis of 20 samples of patients with acute myeloid leukemia (AML) (FAB M0-M5) revealed the expression of NKG2D (40%) and other natural cytotoxicity receptors (40% for NKp30, 74% for NKp44, 39% for NKp46) by a pool >15% of leukemic cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP504912.RAJ432_ETvk8cFlW7POk2UeT1y-sj8FKHvgFntIr9akWA130_provenance.
- NP599880.RALUd_EB8jGY3sjfORcqG7bkCFFkrr5goQ9pqESsMVCxs130_assertion description "[Interestingly, flow cytometry analysis of 20 samples of patients with acute myeloid leukemia (AML) (FAB M0-M5) revealed the expression of NKG2D (40%) and other natural cytotoxicity receptors (40% for NKp30, 74% for NKp44, 39% for NKp46) by a pool >15% of leukemic cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP599880.RALUd_EB8jGY3sjfORcqG7bkCFFkrr5goQ9pqESsMVCxs130_provenance.